tirzepatide online purchase $125/mo Compounded (vs $1,069 Mounjaro) Tirzepatide / Niacinamide Injection |

The reason the FDA cares so much about regulating these products is that compounded GLP-1 medications have generated a measurable, ongoing pattern of patient harm

Pain Res Treat 2018:4901242 Sarzi Puttini P, Caruso I (1992) Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study

Some common additives for GLP-1/GIP medications are B3 (fatigue) or B6 (for nausea)

[DOI] [PMC free article] [PubMed] [Google Scholar] 31.Bibi H

Novo Nordisk (NVO) Trailing P/Es: LLY 38, NOV 10 Forward P/Es: LLY 26, NVO 11 Estimated 2026 sales growth: LLY 26%, NVO -8% Estimated 2025 EPS growth: LLY 43%, NVO -6% Cash per share: LLY $8.14, NVO $6.07 Institutional ownership: LLY 84.6%, NVO 9.5% In terms of value, NVO has LLY beat by a mile, trading at less than a third of LLY on a trailing price-to-earnings basis and just under half of it on a forward price-to-earnings basis